Zantac Users Have Alternative Treatments That Diabetics and Others May Not
The FDA may not be able to issue a drug recall because creating a shortage of the drug might harm more people than the drug defect itself
Saturday, August 29, 2020 - It seems like every month over-the-counter, or prescription drugs are in trouble for having elevated levels of NDMA, a cancer-causing substance. First, it was blood pressure medications, followed by ranitidine, and then metformin, the go-to drug for treating type2 diabetes. The FDA has now found dangerously high levels of NDMA in two generic tuberculosis drugs. The government will not recall the product as doing so may create a shortage that could lead to a new tuberculosis epidemic. The US FDA told consumers, according to Fierce Pharma.com, "Despite finding elevated levels of possible carcinogens in tuberculosis meds rifampin and rifapentine, the FDA will not request a withdrawal from the U.S. shelves over fears a recall would cause a supply shortage."
People that are suffering from high blood pressure, diabetes, and tuberculosis do not have a choice whether or not to take their medication because failing to take it could be life-threatening. Taking anti-heartburn and acid reflux medications like Zantac, on the other hand, could be classified as optional. When it comes to deciding whether to take Zantac, most cases of acid indigestion could be controlled by practicing a healthier, plant-centered diet, and reducing stress. Diabetic, blood pressure and tuberculosis patients that can no longer get their prescription medication are in a life-threatening situation should consult their doctors immediately for alternatives and options. FDA drug recalls could create shortages that may cause more harm to the patient's health than the drug itself.
Zantac was tested and found to contain thousands of times more NDMA than the FDA considers safe. Sanofi, the maker of Zantac and recipient of tens of thousands of Zantac cancer lawsuits, and the FDA removed the product from the market and warned consumers to throw unused portions in the garbage. Unlike patients suffering from high blood pressure, diabetes, and tuberculosis, Zantac patients had many options to choose from to replace their recalled medicine. For them, the recall was more of an inconvenience than anything. What is important for Zantac users is to find out whether or not they have developed Zantac cancer of the stomach, bladder, or another vital organ from repeatedly using the drug. Thousands of Zantac users that have developed cancer of the stomach, bladder, intestines, esophagus, colon, breast, or another type of cancer and have used Zantac are hiring a Zantac Cancer Lawyer to determine if they have a cause to file a claim.
The FDA is developing testing methods to identify drugs that may contain carcinogens like NDMA. Last year, online drug testing pharmacy Valisure rocked the drug industry when it discovered elevated levels of NDMA in Zantac tablets and immediately notified the FDA which had done nothing up until that point in time. Valisure is committed to testing prescription drugs to make sure that they are pure and the company now performs a "carcinogen analysis."
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.